Article metrics

PDF

Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: May 2018 to May 2018

AbstractFullPdf
May 2018770
Total770